Volume 8 Issue 10, Oct 2023

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 8 Issue 10, Oct 2023:
Research Highlight
From Tpex to Tex: a journey through CD8+ T cell responses in cancer immunotherapy
Julia M. Messmer  ORCID: orcid.org/0000-0001-7858-1501,Maike Effern &Michael Hölzel  ORCID: orcid.org/0000-0003-4048-8824